Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Melanoma: An update on systemic therapies
Lauren Skudalski, Reid A. Waldman, Philip Kerr, et al.
Journal of the American Academy of Dermatology (2021) Vol. 86, Iss. 3, pp. 515-524
Closed Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 87
Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases
Qian Lu, Yanli Zhu, Chao Deng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 81
Photosensitizers-Loaded Nanocarriers for Enhancement of Photodynamic Therapy in Melanoma Treatment
Ana-Maria Udrea, Adriana Smarandache, Andra Dinache, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2124-2124
Open Access | Times Cited: 30
Bridging the gap between testing and clinics exploring alternative pre-clinical models in melanoma research
Juliana Santos Rosa Viegas, Bruno Sarmento
Advanced Drug Delivery Reviews (2024) Vol. 208, pp. 115295-115295
Open Access | Times Cited: 12
Multi-scale feature fusion and class weight loss for skin lesion classification
Zhentao Hu, Weiqiang Mei, Hongyu Chen, et al.
Computers in Biology and Medicine (2024) Vol. 176, pp. 108594-108594
Closed Access | Times Cited: 5
IL-2-loaded liposomes modified with sorafenib derivative exert a synergistic anti-melanoma effect via improving tumor immune microenvironment and enhancing antiangiogenic activity
Xuan Huang, Kudelaidi Kuerban, J P Fan, et al.
Asian Journal of Pharmaceutical Sciences (2025), pp. 101020-101020
Open Access
Inequalities in Drug Access for Advanced Melanoma: The Prognostic Impact Resulting From the Approval Delay of the Combined Ipilimumab/Nivolumab Treatment in Portugal
Diana Mata, Sara Coelho, Malene Boas, et al.
Cureus (2025)
Open Access
Fixed-Dose Versus Weight-Adapted Immune Checkpoint Inhibitor Therapy in Melanoma: A Retrospective Monocentric Analysis of Efficacy and Immune-Related Adverse Events
Hans F. Staender, Ewan A. Langan
Cancers (2025) Vol. 17, Iss. 7, pp. 1147-1147
Open Access
Systemic Therapies for Metastatic Melanoma
David I. Latoni, Soo Hyun Kim, Hensin Tsao
Dermatologic Clinics (2025)
Closed Access
Extracellular vesicle-derived non-coding RNAs in remodeling melanoma
Yuanyuan Zhan, Zihui Yang, Hong Zeng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116213-116213
Open Access | Times Cited: 3
Transcriptional switches in melanoma T Cells: Facilitating polarizing into regulatory T cells
Tengda Li, Tianqin Wu, Xiang Li, et al.
International Immunopharmacology (2024) Vol. 137, pp. 112484-112484
Open Access | Times Cited: 3
The Role of Caspases in Melanoma Pathogenesis
A. Szmurło, Klaudia Dopytalska, Michał Szczerba, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 9, pp. 9480-9492
Open Access | Times Cited: 3
Childhood and Adolescent Melanoma: An Update
Patrick McMullan, Jane M. Grant‐Kels
Clinics in Dermatology (2025)
Closed Access
Options of Therapeutics and Novel Delivery Systems of Drugs for the Treatment of Melanoma
Hongbin Wang, Tuan Tran, Katherine T. Duong, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 12, pp. 4487-4505
Closed Access | Times Cited: 16
The role of tumor-associated macrophages and soluble mediators in pulmonary metastatic melanoma
Kaifen Xiong, Min Qi, Tobias Stoeger, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Effervescent cannabidiol solid dispersion-doped dissolving microneedles for boosted melanoma therapy via the “TRPV1-NFATc1-ATF3” pathway and tumor microenvironment engineering
Jiachen Shi, Qiuling Ma, Wenting Su, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 9
Development and validation of ferroptosis-related lncRNA signature and immune-related gene signature for predicting the prognosis of cutaneous melanoma patients
Kaifen Xiong, Zheng Wang, Alphonse Houssou Hounye, et al.
APOPTOSIS (2023) Vol. 28, Iss. 5-6, pp. 840-859
Closed Access | Times Cited: 7
Immunomodulation of Melanoma by Chemo-Thermo-Immunotherapy Using Conjugates of Melanogenesis Substrate NPrCAP and Magnetite Nanoparticles: A Review
Yasuaki Tamura, Akira Itô, Kazumasa Wakamatsu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6457-6457
Open Access | Times Cited: 12
Immune checkpoint inhibitors as first line in advanced melanoma: Evaluating progression‐free survival based on reconstructed individual patient data
Andrea Ossato, Vera Damuzzo, Paolo Baldo, et al.
Cancer Medicine (2022) Vol. 12, Iss. 3, pp. 2155-2165
Open Access | Times Cited: 12
Adjuvant Therapy for High-Risk Melanoma: An In-Depth Examination of the State of the Field
Islam Eljilany, Ella Castellano, Ahmad A. Tarhini
Cancers (2023) Vol. 15, Iss. 16, pp. 4125-4125
Open Access | Times Cited: 6
Genes associated with cellular senescence favor melanoma prognosis by stimulating immune responses in tumor microenvironment
Xiaofeng Liang, Xiaobing Lin, Zien Lin, et al.
Computers in Biology and Medicine (2023) Vol. 158, pp. 106850-106850
Closed Access | Times Cited: 5
α-Mangostin Suppresses Melanoma Growth, Migration, and Invasion and Potentiates the Anti-tumor Effect of Chemotherapy
Yuxiu Xie, Chongwen Gong, Yun Xia, et al.
International Journal of Medical Sciences (2023) Vol. 20, Iss. 9, pp. 1220-1234
Open Access | Times Cited: 5
Is obesity a risk factor for melanoma?
Yuval Arbel, Yifat Arbel, Amichai Kerner, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Abscopal effect observed in visceral and osseous metastases after liver SBRT in combination with nivolumab and relatlimab for sinonasal mucosal melanoma—a case report
Danielle Cerbon, Karen Moya-Brown, I Mihaylov, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Integration of single-cell and bulk RNA sequencing data reveals that CYTOR is a potential prognostic and immunotherapeutic response marker for skin cutaneous melanoma
Ming Zhang, Yikun Ju, Lei Xue, et al.
Journal of Cancer (2024) Vol. 15, Iss. 12, pp. 3890-3902
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top